Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 3, 2022 21:03 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionCommon Stock | 11,215 | $18.81 | $210,954.15 |
DisclosureSEC source: 0001127602-22-007962 · form4.xml · nonDerivative · entry 2 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:03 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,905 | $33.32 | $230,074.60 |
DisclosureSEC source: 0001127602-22-007962 · form4.xml · nonDerivative · entry 1 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:04 UTC |
GULIS STEPHEN L JRDirector
|
GiftCommon Stock | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007302 · form4.xml · nonDerivative · entry 1 GULIS STEPHEN L JR · CIK 0001015788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,646 F1 · balance_after: Includes 820 restricted stock units that will vest over time and 23,996 deferred shares. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:03 UTC |
Alegre DanielDirector
|
SaleCommon Stock | 17,000 | $65.89 | $1,120,130.00 |
DisclosureSEC source: 0001127602-22-007301 · form4.xml · nonDerivative · entry 1 Alegre Daniel · CIK 0001576237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,913 F1 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:02 UTC |
LAUDERBACK BRENDA JDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,499 | $0.00 Strike: $27.45 | $0.00 |
DisclosureSEC source: 0001127602-22-007300 · form4.xml · derivative · entry 3 LAUDERBACK BRENDA J · CIK 0001160672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,499 shares Expires 2022-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on 5/30/13. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:02 UTC |
LAUDERBACK BRENDA JDirector
|
SaleCommon Stock | 1,660 | $63.35 | $105,161.00 |
DisclosureSEC source: 0001127602-22-007300 · form4.xml · nonDerivative · entry 2 LAUDERBACK BRENDA J · CIK 0001160672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,188 F1 · balance_after: Includes 820 restricted stock units that will vest over time and 10,388 deferred shares. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:02 UTC |
LAUDERBACK BRENDA JDirector
|
Exercise / conversionCommon Stock | 2,499 | $27.45 | $68,597.55 |
DisclosureSEC source: 0001127602-22-007300 · form4.xml · nonDerivative · entry 1 LAUDERBACK BRENDA J · CIK 0001160672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2022 Filed Jan 13, 2022 21:00 UTC |
Bloomquist Andrea LeeEVP, Chief Innovation Officer
|
OtherCommon Stock | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001446 · form4.xml · nonDerivative · entry 1 Bloomquist Andrea Lee · CIK 0001551521 · EVP, Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Inherited Securities Disclosed balance after: 603 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:02 UTC |
Alegre DanielDirector
|
GrantCommon Stock | 278 | $76.28 | $21,205.84 |
DisclosureSEC source: 0001127602-21-031339 · form4.xml · nonDerivative · entry 1 Alegre Daniel · CIK 0001576237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,913 F1 · shares: The reporting person elected to receive his Board fees in common stock. F2 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:01 UTC |
Nedorostek Kathleen LDirector
|
GrantPhantom Stock · Derivative | 278.5789 | $76.28 | $21,250.00 |
DisclosureSEC source: 0001127602-21-031337 · form4.xml · derivative · entry 2 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,418.7655 Underlying: Common Stock · 278.5789 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:00 UTC |
Matas Barbara RuthDirector
|
GrantPhantom Stock · Derivative | 344.1269 | $76.28 | $26,250.00 |
DisclosureSEC source: 0001127602-21-031334 · form4.xml · derivative · entry 2 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,551.5166 Underlying: Common Stock · 344.1269 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:00 UTC |
HARRISON MICHAEL JDirector
|
GiftCommon Stock | 39,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028799 · form4.xml · nonDerivative · entry 2 HARRISON MICHAEL J · CIK 0001267858 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 39,715 Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:00 UTC |
HARRISON MICHAEL JDirector
|
GiftCommon Stock | 39,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028799 · form4.xml · nonDerivative · entry 1 HARRISON MICHAEL J · CIK 0001267858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,943 F1 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,255 | $0.00 Strike: $18.81 | $0.00 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · derivative · entry 8 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,255 shares Expires 2026-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,935 | $0.00 Strike: $23.61 | $0.00 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · derivative · entry 7 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,935 shares Expires 2027-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
SaleCommon Stock | 8,255 | $89.79 | $741,219.75 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · nonDerivative · entry 5 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $89.25 and $90.70, inclusive. The reporting person will provide the SEC Staff, Sleep Number or any security holder of Sleep Number, upon request, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 6,559 restricted stock units that the reporting person has deferred. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
Exercise / conversionCommon Stock | 8,255 | $18.81 | $155,276.55 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · nonDerivative · entry 4 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
SaleCommon Stock | 7,935 | $89.79 | $712,486.82 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · nonDerivative · entry 3 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,719 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $89.25 and $90.70, inclusive. The reporting person will provide the SEC Staff, Sleep Number or any security holder of Sleep Number, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
Exercise / conversionCommon Stock | 7,935 | $23.61 | $187,345.35 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · nonDerivative · entry 2 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 20:00 UTC |
Nedorostek Kathleen LDirector
|
GiftCommon Stock | 4,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028455 · form4.xml · nonDerivative · entry 1 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,021 F1 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:01 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,705 | $0.00 Strike: $34.35 | $0.00 |
DisclosureSEC source: 0001127602-21-028456 · form4.xml · derivative · entry 4 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,705 shares Expires 2028-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This stock option is fully vested and exercisable. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:01 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
SaleCommon Stock | 1,705 | $91.00 | $155,155.00 |
DisclosureSEC source: 0001127602-21-028456 · form4.xml · nonDerivative · entry 2 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,440 F1 · balance_after: Includes 2,778 restricted stock units that vest over time. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:01 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
Exercise / conversionCommon Stock | 1,705 | $34.35 | $58,566.75 |
DisclosureSEC source: 0001127602-21-028456 · form4.xml · nonDerivative · entry 1 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:50 UTC |
Brown Kevin KennedyEVP and CMO
|
GiftCommon Stock | 548 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028490 · form4.xml · nonDerivative · entry 1 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,719 Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:02 UTC |
Alegre DanielDirector
|
GrantCommon Stock | 210 | $101.19 | $21,249.90 |
DisclosureSEC source: 0001127602-21-025808 · form4.xml · nonDerivative · entry 1 Alegre Daniel · CIK 0001576237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,635 F1 · shares: The reporting person elected to receive his Board fees in common stock. F2 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:01 UTC |
Matas Barbara RuthDirector
|
GrantPhantom Stock · Derivative | 259.413 | $101.19 | $26,250.00 |
DisclosureSEC source: 0001127602-21-025807 · form4.xml · derivative · entry 2 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,207.3897 Underlying: Common Stock · 259.413 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:00 UTC |
Nedorostek Kathleen LDirector
|
GrantPhantom Stock · Derivative | 210.001 | $101.19 | $21,250.00 |
DisclosureSEC source: 0001127602-21-025805 · form4.xml · derivative · entry 2 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,140.1866 Underlying: Common Stock · 210.001 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:00 UTC |
Hellfeld Samuel RSVP Chief Legal & Risk Officer
|
Tax withholdingCommon Stock | 4,324 | $93.93 | $406,153.32 |
DisclosureSEC source: 0001127602-21-025646 · form4.xml · nonDerivative · entry 2 Hellfeld Samuel R · CIK 0001750478 · SVP Chief Legal & Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,216 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award and a restricted stock unit award to cover the estimated tax withholding obligation. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:00 UTC |
Hellfeld Samuel RSVP Chief Legal & Risk Officer
|
GrantCommon Stock | 6,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025646 · form4.xml · nonDerivative · entry 1 Hellfeld Samuel R · CIK 0001750478 · SVP Chief Legal & Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,540 F1 · shares: On 9/20/21 shares vested from a performance-based restricted stock unit award. Read SEC document |
| July 23, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,290 | $0.00 Strike: $33.32 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · derivative · entry 9 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,905 Underlying: Common Stock · 3,290 shares Expires 2025-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 23, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 3,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 6 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 157,714 Read SEC document |
| July 23, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 3,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 5 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,009 F1 · balance_after: Includes 88,009 restricted stock units which the reporting person has deferred. Read SEC document |
| July 23, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,290 | $33.32 | $109,622.80 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 4 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,820 | $0.00 Strike: $33.32 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · derivative · entry 8 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,195 Underlying: Common Stock · 4,820 shares Expires 2025-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 4,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 3 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 154,424 Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 4,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 2 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,009 F1 · balance_after: Includes 88,009 restricted stock units which the reporting person has deferred. Read SEC document |
| July 22, 2021 Filed Jul 23, 2021 20:25 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,820 | $33.32 | $160,602.40 |
DisclosureSEC source: 0001127602-21-022433 · form4.xml · nonDerivative · entry 1 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:00 UTC |
Alegre DanielDirector
|
SaleCommon Stock | 12,852 | $107.55 | $1,382,232.60 |
DisclosureSEC source: 0001127602-21-018059 · form4.xml · nonDerivative · entry 1 Alegre Daniel · CIK 0001576237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,425 F1 · balance_after: Includes 820 restricted stock units that will vest over time. Read SEC document |
| May 25, 2021 Filed Jun 1, 2021 20:00 UTC |
Hellfeld Samuel RSVP Chief Legal & Risk Officer
|
OtherCommon Stock | 1,878.2227 | $107.61 | $202,115.54 |
DisclosureSEC source: 0001127602-21-018457 · form4.xml · nonDerivative · entry 1 Hellfeld Samuel R · CIK 0001750478 · SVP Chief Legal & Risk Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by 401k Disclosed balance after: 3,998.0172 Read SEC document |
| May 24, 2021 Filed May 27, 2021 20:00 UTC |
Callen David REVP & CFO
|
OtherCommon Stock | 2,947.0365 | $106.11 | $312,699.73 |
DisclosureSEC source: 0001127602-21-018163 · form4.xml · nonDerivative · entry 1 Callen David R · CIK 0001418784 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by 401(k) Disclosed balance after: 2,947.0365 Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:26 UTC |
VALETTE JEAN MICHELDirector
|
GrantStock Option (right to buy) · Derivative | 545 | $0.00 Strike: $106.54 | $0.00 |
DisclosureSEC source: 0001127602-21-016854 · form4.xml · derivative · entry 2 VALETTE JEAN MICHEL · CIK 0001199207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 Underlying: Common Stock · 545 shares Expires 2031-05-12 Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:26 UTC |
VALETTE JEAN MICHELDirector
|
GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016854 · form4.xml · nonDerivative · entry 1 VALETTE JEAN MICHEL · CIK 0001199207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,337 F1 · balance_after: Includes 820 shares pursuant to a restricted stock unit award that vest over time. On 5/12/21, 1,815 shares vested from a restricted stock unit award. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:24 UTC |
Nedorostek Kathleen LDirector
|
GrantPhantom Stock · Derivative | 199.4556 | $106.54 | $21,250.00 |
DisclosureSEC source: 0001127602-21-016851 · form4.xml · derivative · entry 3 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,930.1856 Underlying: Common Stock · 199.4556 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:24 UTC |
Nedorostek Kathleen LDirector
|
GrantStock Option (right to buy) · Derivative | 545 | $0.00 Strike: $106.54 | $0.00 |
DisclosureSEC source: 0001127602-21-016851 · form4.xml · derivative · entry 2 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 Underlying: Common Stock · 545 shares Expires 2031-05-12 Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:24 UTC |
Nedorostek Kathleen LDirector
|
GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016851 · form4.xml · nonDerivative · entry 1 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,816 F1 · balance_after: Includes 820 restricted stock units that will vest over time. On 5/12/21, 1,815 shares vested from a restricted stock unit award. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:22 UTC |
Matas Barbara RuthDirector
|
GrantPhantom Stock · Derivative | 239.3467 | $106.54 | $25,500.00 |
DisclosureSEC source: 0001127602-21-016845 · form4.xml · derivative · entry 3 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,947.9767 Underlying: Common Stock · 239.3467 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:22 UTC |
Matas Barbara RuthDirector
|
GrantStock Option (right to buy) · Derivative | 545 | $0.00 Strike: $106.54 | $0.00 |
DisclosureSEC source: 0001127602-21-016845 · form4.xml · derivative · entry 2 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 Underlying: Common Stock · 545 shares Expires 2031-05-12 Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:22 UTC |
Matas Barbara RuthDirector
|
GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016845 · form4.xml · nonDerivative · entry 1 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,686 F1 · balance_after: Includes 820 restricted stock units that will vest over time. On 5/12/21, 1,815 shares vested from a restricted stock unit award and the reporting person has deferred receipt of those shares. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:21 UTC |
LAUDERBACK BRENDA JDirector
|
GrantStock Option (right to buy) · Derivative | 545 | $0.00 Strike: $106.54 | $0.00 |
DisclosureSEC source: 0001127602-21-016841 · form4.xml · derivative · entry 2 LAUDERBACK BRENDA J · CIK 0001160672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 Underlying: Common Stock · 545 shares Expires 2031-05-12 Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:21 UTC |
LAUDERBACK BRENDA JDirector
|
GrantCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016841 · form4.xml · nonDerivative · entry 1 LAUDERBACK BRENDA J · CIK 0001160672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,349 F1 · balance_after: Includes 820 restricted stock units that will vest over time. On 5/12/21, 1,815 shares vested from a restricted stock unit award and the reporting person has deferred receipt of the shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.